Vaxcyte Inc (PCVX)

Nov 18, 2024

Victory Capital Management Inc. Has $29.14 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 18, 2024

Nov 17, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) Receives Average Recommendation of "Buy" from Analysts - MarketBeat

Nov 17, 2024

Nov 16, 2024

Curi RMB Capital LLC Purchases New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 16, 2024

Nov 16, 2024

Los Angeles Capital Management LLC Takes $1.02 Million Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 16, 2024

Nov 15, 2024

Vaxcyte (NASDAQ:PCVX) Sees Unusually-High Trading VolumeWhat's Next? - MarketBeat

Nov 15, 2024

Nov 15, 2024

RA Capital Management, L.P. Increases Stake in Vaxcyte Inc - GuruFocus.com

Nov 15, 2024

Nov 14, 2024

Janus Henderson Group PLC's Strategic Acquisition of Vaxcyte Inc Shares - GuruFocus.com

Nov 14, 2024

Nov 14, 2024

Long Term Trading Analysis for (PCVX) - Stock Traders Daily

Nov 14, 2024

Nov 13, 2024

Vaxcyte Enters Oversold Territory (PCVX) - Nasdaq

Nov 13, 2024

Nov 13, 2024

FMR LLC Adjusts Stake in Vaxcyte Inc - GuruFocus.com

Nov 13, 2024

Nov 12, 2024

Vaxcyte provides regulatory updates on VAX-31 programs - TipRanks

Nov 12, 2024

Nov 12, 2024

FDA advances Vaxcyte's pneumococcal vaccine VAX-31 By Investing.com - Investing.com Canada

Nov 12, 2024

Nov 12, 2024

FDA advances Vaxcyte's pneumococcal vaccine VAX-31 - Investing.com

Nov 12, 2024

Nov 12, 2024

Vaxcyte Provides Positive Regulatory Updates on VAX-31 Pediatric and Adult Programs - The Bakersfield Californian

Nov 12, 2024

Nov 12, 2024

WCM Investment Management LLC Has $15.94 Million Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 12, 2024

Nov 11, 2024

Lisanti Capital Growth LLC Purchases 13,175 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 11, 2024

Nov 11, 2024

Cantor Fitzgerald Increases Earnings Estimates for Vaxcyte - MarketBeat

Nov 11, 2024

Nov 10, 2024

TimesSquare Capital Management LLC Buys New Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 10, 2024

Nov 09, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) CEO Sells $245,803.74 in Stock - MarketBeat

Nov 09, 2024

Nov 08, 2024

Vaxcyte CEO Grant Pickering sells $245,796 in company stock - Investing.com India

Nov 08, 2024

Nov 08, 2024

Vaxcyte CEO Grant Pickering sells $245,796 in company stock By Investing.com - Investing.com Australia

Nov 08, 2024

Nov 08, 2024

FY2024 EPS Estimates for Vaxcyte Raised by Leerink Partnrs - MarketBeat

Nov 08, 2024

Nov 07, 2024

We're Hopeful That Vaxcyte (NASDAQ:PCVX) Will Use Its Cash Wisely - Yahoo Finance

Nov 07, 2024

Nov 07, 2024

Vaxcyte, Inc. Navigates AI Risks Amidst Regulatory and Ethical Challenges - TipRanks

Nov 07, 2024

Nov 06, 2024

Vaxcyte's (PCVX) Overweight Rating Reaffirmed at Cantor Fitzgerald - MarketBeat

Nov 06, 2024

Nov 06, 2024

Vaxcyte's (PCVX) "Buy" Rating Reiterated at Needham & Company LLC - MarketBeat

Nov 06, 2024

Nov 06, 2024

Vaxcyte stock target lifted as analyst sees VAX-31 leading in clinical advancement - Investing.com UK

Nov 06, 2024

Nov 06, 2024

Leerink Partners reaffirms Outperform on Vaxcyte stock with bullish pipeline outlook - Investing.com UK

Nov 06, 2024

Nov 06, 2024

Decoding Vaxcyte Inc (PCVX): A Strategic SWOT Insight - GuruFocus.com

Nov 06, 2024

Nov 05, 2024

Vaxcyte Reports Progress and Strengthens Financial Position - TipRanks

Nov 05, 2024

Nov 05, 2024

Vaxcyte Inc (PCVX) Reports Q3 2024 Net Loss of $103.1 Million Am - GuruFocus.com

Nov 05, 2024

Nov 05, 2024

Vaxcyte Reports Third Quarter 2024 Financial Results and Provides Business Update - The Manila Times

Nov 05, 2024

Nov 05, 2024

Vaxcyte's VAX-31 Vaccine Shows Promise in Phase 1/2, Plans Phase 3 Amid $3.3B Cash Position | PCVX Stock News - StockTitan

Nov 05, 2024

Nov 04, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) COO Jim Wassil Sells 8,000 Shares - MarketBeat

Nov 04, 2024

Nov 04, 2024

Vaxcyte CEO Grant Pickering sells shares worth $1.6 million By Investing.com - Investing.com Australia

Nov 04, 2024

Nov 04, 2024

Vaxcyte COO Jim Wassil sells $854k in stock - Investing.com

Nov 04, 2024

Nov 04, 2024

Vaxcyte CEO Grant Pickering sells shares worth $1.6 million - Investing.com

Nov 04, 2024

Nov 04, 2024

Vaxcyte COO Jim Wassil sells $854k in stock By Investing.com - Investing.com UK

Nov 04, 2024

Nov 03, 2024

Harbor Capital Advisors Inc. Has $7.39 Million Stock Holdings in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Nov 03, 2024

Nov 01, 2024

Should You Consider Investing in Vaxcyte (PCVX)? - Insider Monkey

Nov 01, 2024

Oct 30, 2024

Raymond James & Associates Buys 11,798 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 30, 2024

Oct 29, 2024

Vaxcyte’s stock flat as biotech preps to complete $1.42 billion stock offering - MSN

Oct 29, 2024

Oct 29, 2024

Vaxcyte (NASDAQ:PCVX) Trading Down 5.9%Time to Sell? - MarketBeat

Oct 29, 2024

Oct 29, 2024

China Universal Asset Management Co. Ltd. Grows Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 29, 2024

Oct 27, 2024

Novo Holdings A S Has $85.70 Million Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 27, 2024

Oct 25, 2024

Creative Planning Buys 10,245 Shares of Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 25, 2024

Oct 24, 2024

Vaxcyte stock holds $160 target with Buy rating from BTIG By Investing.com - Investing.com Canada

Oct 24, 2024

Oct 24, 2024

Moody Aldrich Partners LLC Trims Stock Position in Vaxcyte, Inc. (NASDAQ:PCVX) - MarketBeat

Oct 24, 2024

Oct 23, 2024

How To Trade (PCVX) - Stock Traders Daily

Oct 23, 2024

Oct 23, 2024

Vaxcyte, Inc. (NASDAQ:PCVX) Receives $147.50 Average Price Target from Brokerages - MarketBeat

Oct 23, 2024